For researchers with a history of gallbladder problems, existing gallstones, or other biliary risk factors like rapid previous weight loss episodes or high BMI, this difference should factor into their medication choice
Furthermore, it is possible regulators may require evidence of additional benefits beyond body composition for the approval of muscle-preserving therapies, such as incremental weight loss above background therapy for combinations or patient-relevant outcomes
Semaglutide, an injectable drug already approved by the Food and Drug Administration as a treatment for Type 2 diabetes, produced moderate weight loss at a titrated dose of 1mg & increasing to 2.4mg weekly
FDA states directly that compounded drugs should be used only for patients whose medical needs cannot be met by an FDA-approved drug, or where the FDA-approved drug isn't commercially available - whether that standard applies to a given patient is a clinical question for the prescribing provider to work through with you, not something this article, or Zevay's marketing, can answer in advance
10.1007/s00392-023-02254-9 45
Crossing time zones When you cross time zones, the clock changes but your biology does not
